BDCI Industry Seminar Series

The BDCI Industry Seminar Series is held monthly during the academic year and aims to both expose Emory trainees and faculty to novel research happening in the industry setting, but also to provide career development opportunities for trainees interested in a career in industry. 

To date, we have hosted industry leaders from top pharmaceutical companies, including:

• Pfizer
  • Speaker: Chris am Ende
  • Development of chemical biology probes for applications in drug discovery
• Merck 
  • Speaker: Anilkumar Nair
  • Macrocyclic peptides targeting protein-protein interactions: Discovery of oral PCSK9 inhibitors for lowering LDL-C
• AbbVie
  
  • Speakers: Tim Hodges & Eric Voight
  • Discovery of a CFTR-C2 corrector for cystic fibrosis: Design, synthesis, and the AbbVie/Emory collaboration
• Novartis
  • Speakers: Art Cernijenko & Kian Tan
  • Discovery of a first-in-class molecular glue degrader for immuno-oncology indications
  • Application of synthesis and technology to accelerate drug discovery

Stay tuned for our full lineup of speakers for Fall 2022. Already confirmed: 

• Friday, September 30th: Foghorn Therapeutics
  • Speaker: Danette Daniels, VP of Protein Degradation Platform 
  • Characterizing PROTAC degraders and bringing them into the clinic
  • 12-1 PM in O. Wayne Rollins Research Center, Room 5052
    • Pharmacology and Chemical Biology Conference Room